Henry Schein (HSIC) 2026 Global Healthcare Conference summary
Event summary combining transcript, slides, and related documents.
2026 Global Healthcare Conference summary
15 Sep, 2026Leadership transition and organizational priorities
New CEO expresses strong optimism and sees greater opportunities after six months in the role.
Employees have responded positively to leadership change, viewing it as refreshing and necessary for improvement.
Three main priorities: accelerating growth, simplifying operations, and increasing operating rigor.
Focus on maintaining and deepening trusted relationships with customers and suppliers.
Emphasis on leveraging the company’s culture and 26,000 team members for continued success.
Financial performance and growth initiatives
Targeting $200 million in operating income improvement over the next two to three years, with a focus on net improvement to the bottom line.
Improvements include enhanced pricing processes and outsourcing back office functions like finance and customer service.
Commitment to double-digit EPS growth in the near term, driven by operational improvements and accelerated business growth.
Ongoing efforts to scale efficiently and standardize processes for long-term benefits.
Market trends and business segments
U.S. dental market remains steady, with the company outpacing market growth and gaining share.
European dental market is growing, especially in specialty and implant segments, with faster growth in value implants.
Majority ownership of S.I.N. value implant business in the U.S. is supporting strategic positioning.
Clear aligners and orthodontics are a small but growing part of the business, with strong regional performance in France.
Latest events from Henry Schein
- Global leader in dental and medical products with $13.2B sales and strong growth momentum.HSIC
Corporate presentation - Q2 2026 saw strong sales, margin gains, and raised guidance, with robust segment growth.HSIC
Q2 2026 - Strategic initiatives and value creation projects drive stable growth and operational efficiency.HSIC
Baird Global Healthcare Conference 2025 - Transformation, innovation, and disciplined growth drive strong outlook and value creation.HSIC
Stifel Jaws & Paws Conference 2026 - Leadership changes, all proposals passed, and majority voting adopted for future governance.HSIC
AGM 2026 - Strong Q1 growth, margin expansion, and strategic focus position the company for 2026 targets.HSIC
Bank of America Global Healthcare Conference 2026 - Record Q3 2025 results, raised guidance, and $200M+ value creation initiatives announced.HSIC
Q3 2025 - Q2 2024 sales up 1.1% to $3.14B; net income and EPS declined, and guidance was reduced.HSIC
Q2 2024 - Q4 2024 non-GAAP EPS rose 80% on 5.8% sales growth; 2025 outlook targets steady gains.HSIC
Q4 2024